Neostigmine Methylsulfate Injection
Product Images NDC 70121-1479

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 70121-1479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Neostigmine Methylsulfate Injection 1)

FDA Label Image

1 (Neostigmine Methylsulfate Injection 2)

FDA Label Image

1 (Neostigmine Methylsulfate Injection 3)

1 (Neostigmine Methylsulfate Injection 3)
Neostigmine Methylsulfate Injection is a medicine used for Intravenous Use packed in 10x 10 mL Multiple-Dose Vials. It contains 5mg/10 mL (0.5 my/ml) of Neostigmine Methylsulfate. The package is designed to be stored between 20 to 25°C (68 to 77°F), with excursions permitted at 15° to 30°C (59" to 86°F), and protected from light. The directions for use are available on the package. The manufacturer of Neostigmine Methylsulfate Injection is Amnea Pharmaceuticls Pt Lt.*
FDA Label Image

1 (Neostigmine Methylsulfate Injection 4)

1 (Neostigmine Methylsulfate Injection 4)
This is a description of a medication with the National Drug Code (NDC) 7012114781. The medication is Neostigmine Methylsulfate Injection intended for intravenous use, contained in a vial with a volume of 10 mL. The concentration of the medication in the vial is 1mg/mL. There is no further available information.*
FDA Label Image

1 (Neostigmine Methylsulfate Injection 5)

1 (Neostigmine Methylsulfate Injection 5)
Neostigmine Methylsulfate Injection, USP is a medication administered intravenously using 10 x 10 mL multiple-dose vials. Each milliliter contains Neostigmine Methylsulfate (1 mg), Phend (4.5 mg), and Sodum Aectte Tycate (0.2 mg). The solution is prepared by adjusting the pH with Sodum Hybou/iceic cd when necessary. The solution should be stored at 2° to 25°C, protected from light and excursions allowed between 5° to 30°C. The vial stopper is made of natural rubber.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.